[1]
A. ASNAWI, E. FEBRINA, W. ALIGITA, D. KURNIA, L. O. AMAN, and A. YULIANTINI, “SCREENING OF ASHITABA (ANGELICA KEISKEI K.) COMPOUNDS AS POTENTIAL MYCOBACTERIUM TUBERCULOSIS KASA INHIBITORS”, Int J App Pharm, vol. 14, no. 5, pp. 80–85, Dec. 2022.